Laverty joins Eisai

Share this article:
Eisai has named longtime pharma communicator Robert Laverty to the newly created position of VP of US communications.

Laverty joins Eisai from Novartis, where he served as VP, global communications, malaria initiatives.

A 22-year industry veteran, Laverty has previously held several other executive titles at Novartis including VP, external communication and VP, global pharma media relations. 

Prior to joining Novartis, Laverty worked in several corporate policy, corporate affairs, and product public affairs positions at Bristol-Myers Squibb Company.
Share this article:

Email Newsletters

More in News

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.

Amgen Q2 sales rise, company to lay off up to 2,900

Amgen Q2 sales rise, company to lay off ...

The majority of the layoffs will be in the US.

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...